Volkswagen blamed bad planning by suppliers in compounding the computer chip shortage in the global auto industry.
According to the German carmaker, it informed its suppliers in April last year that it expected strong recovery in the second half of 2020.
At that time, much of global car production was idled due to the pandemic.
Despite the heads up, Volkswagen was notified one of its suppliers at the end of November of a chip shortage.
According to a Volkswagen executive, if suppliers do not trust their numbers and have to consult their forecasts, then they should have been informed straight away.
In December, Volkswagen became the first carmaker to warn of a chip supply crunch, forcing them to cut or halt production.
Representatives for Continental and Robert Bosch, the world’s two largest automotive suppliers, said they would not comment on customer relations.
Continental said it has been open and transparent with clients while
Bosch noted that it was doing everything to supply customers and keep impact to a minimum.
Volkswagen, which so far only procures chips via suppliers, would consider sourcing straight from manufacturers to protect its supply.


Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
OpenAI Tightens AI Safety Monitoring After Security Incidents
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Google to Move All Pixel Production Out of China by 2027
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Coty Revenue Beats Estimates as Beauty Demand Holds Firm 



